187 related articles for article (PubMed ID: 12482878)
1. Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells.
Podar K; Tai YT; Cole CE; Hideshima T; Sattler M; Hamblin A; Mitsiades N; Schlossman RL; Davies FE; Morgan GJ; Munshi NC; Chauhan D; Anderson KC
J Biol Chem; 2003 Feb; 278(8):5794-801. PubMed ID: 12482878
[TBL] [Abstract][Full Text] [Related]
2. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
Tu Y; Gardner A; Lichtenstein A
Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
[TBL] [Abstract][Full Text] [Related]
3. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM
Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling.
Ushio-Fukai M; Hilenski L; Santanam N; Becker PL; Ma Y; Griendling KK; Alexander RW
J Biol Chem; 2001 Dec; 276(51):48269-75. PubMed ID: 11585822
[TBL] [Abstract][Full Text] [Related]
5. Effect of cholesterol depletion on mitogenesis and survival: the role of caveolar and noncaveolar domains in insulin-like growth factor-mediated cellular function.
Matthews LC; Taggart MJ; Westwood M
Endocrinology; 2005 Dec; 146(12):5463-73. PubMed ID: 16166225
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib.
Podar K; Shringarpure R; Tai YT; Simoncini M; Sattler M; Ishitsuka K; Richardson PG; Hideshima T; Chauhan D; Anderson KC
Cancer Res; 2004 Oct; 64(20):7500-6. PubMed ID: 15492276
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 as a potential new therapeutic target in multiple myeloma.
Podar K; Anderson KC
Cancer Lett; 2006 Feb; 233(1):10-5. PubMed ID: 16473666
[TBL] [Abstract][Full Text] [Related]
8. Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells.
Podar K; Mostoslavsky G; Sattler M; Tai YT; Hayashi T; Catley LP; Hideshima T; Mulligan RC; Chauhan D; Anderson KC
J Biol Chem; 2004 May; 279(20):21658-65. PubMed ID: 15010462
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I activation of Akt survival cascade in neuronal cells requires the presence of its cognate receptor in caveolae.
Lu X; Kambe F; Cao X; Yamauchi M; Seo H
Exp Cell Res; 2008 Jan; 314(2):342-51. PubMed ID: 18022157
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
Ravid D; Maor S; Werner H; Liscovitch M
Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
[TBL] [Abstract][Full Text] [Related]
11. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo.
Sedding DG; Hermsen J; Seay U; Eickelberg O; Kummer W; Schwencke C; Strasser RH; Tillmanns H; Braun-Dullaeus RC
Circ Res; 2005 Apr; 96(6):635-42. PubMed ID: 15731459
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I is a dual effector of multiple myeloma cell growth.
Ge NL; Rudikoff S
Blood; 2000 Oct; 96(8):2856-61. PubMed ID: 11023522
[TBL] [Abstract][Full Text] [Related]
14. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
15. Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I.
Matthews LC; Taggart MJ; Westwood M
Endocrinology; 2008 Oct; 149(10):5199-208. PubMed ID: 18583416
[TBL] [Abstract][Full Text] [Related]
16. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the caveolin-3 and Akt status in caveolae by insulin resistance in H9c2 cardiomyoblasts.
Ha H; Pak Y
Exp Mol Med; 2005 Jun; 37(3):169-78. PubMed ID: 16000870
[TBL] [Abstract][Full Text] [Related]
18. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
Mitsiades CS; Mitsiades N; Poulaki V; Schlossman R; Akiyama M; Chauhan D; Hideshima T; Treon SP; Munshi NC; Richardson PG; Anderson KC
Oncogene; 2002 Aug; 21(37):5673-83. PubMed ID: 12173037
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I-stimulated Akt phosphorylation and oligodendrocyte progenitor cell survival require cholesterol-enriched membranes.
Romanelli RJ; Mahajan KR; Fulmer CG; Wood TL
J Neurosci Res; 2009 Nov; 87(15):3369-77. PubMed ID: 19382214
[TBL] [Abstract][Full Text] [Related]
20. Promotion of human mesenchymal stem cell osteogenesis by PI3-kinase/Akt signaling, and the influence of caveolin-1/cholesterol homeostasis.
Baker N; Sohn J; Tuan RS
Stem Cell Res Ther; 2015 Dec; 6():238. PubMed ID: 26626726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
